DVL3 blocking peptide product blog
Tags: Blocking Peptide; DVL3; DVL3 blocking peptide;
The DVL3 dvl3 (Catalog #MBS9218808) is a Blocking Peptide and is intended for research purposes only. The product is available for immediate purchase.The DVL3 dvl3 product has the following accession number(s) (GI #6919875) (NCBI Accession #Q92997.2) (Uniprot Accession #Q92997). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
May play a role in the signal transduction pathway mediated by multiple Wnt genes.
Cellular Location: Cytoplasm. The following patways have been known to be associated with this gene. Breast Neoplasms, Cardiovascular Abnormalities, Cardiovascular Diseases, Dementia, Embryo Loss, Memory Disorders, Neoplasm Metastasis, Neoplasms, Experimental, Nervous System Diseases, Uterine Cervical Neoplasms are some of the diseases may be linked to DVL3 Antibody (C-term) Blocking peptide. DVL3 also interacts with the following gene(s): AXIN1, CTNNB1, LRP5, LRP6, NKD1, PRICKLE1, VANGL1, WNT3A. Blood, Bone, Brain, Embryonic Tissue, Heart, Kidney, Lung, Nerve, Ovary, Prostate tissues are correlated with this protein.